Clinical Study of PAL-222 Targeting Patients With Refractory Skin Ulcer

NCT07016438 · clinicaltrials.gov ↗

NA

Phase

RECRUITING

Status

6

Enrollment

INDUSTRY

Sponsor class

Conditions

Refractory Skin Ulcer

Interventions

PROCEDURE: Transplant surgery

Sponsor

PharmaBio Corporation